Evolve Biologics

IN THE PRESS

Business

Evolve Biologics® Announces Appointment of New Chief Financial Officer

September 6, 2022

·

3 min read

Business

Evolve Biologics® Confirms Selection of DPR Construction as General Contractor for First Manufacturing Facility in Texas, Demonstrating Further Progress Toward Commercialization of Its Innovative PlasmaCap EBA® Technology

May 17, 2021

·

3 min read

Evolve Biologics Provides Business Update on Progress Toward Commercialization of Innovative PlasmaCap EBA® Technology

March 10, 2021

·

3 min read

Drug Development

Evolve Biologics® Completes Phase III Adult and Pediatric Trials for PlasmaCap™ IG (Intravenous Immunoglobulin)

February 9, 2021

·

5 min read

Drug Development

Evolve Biologics™ Provides Update on Progress in Phase III Trial for PlasmaCap™ IG (Intravenous Immunoglobulin)

September 25, 2018

·

6 min read

Drug Development

Evolve Biologics™ Reaches Major Milestones in Phase III Trial for PlasmaCap™ IG (Intravenous Immunoglobulin), Including Dosing of First Pediatric Patient

May 4, 2018

·

5 min read

Deals

Evolve Biologics, Therapure Biopharma’s Biologics Division, Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

March 28, 2018

·

1 min read

JOBS